Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Zoledronic acid

EU orphan designation number: EU/3/16/1735   
Active ingredient: Zoledronic acid
Indication: Treatment of glioma
Sponsor: Laboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A.
via Licinio, 11, 22036 Erba (CO), Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/067/16 (2016)5643 of 29/08/2016